newsfilter
← Latest News
PR Newswire·

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4...